HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

HC Wainwright & Co. analyst Arthur He has reiterated a Buy rating on Adagene (NASDAQ: ADAG) and maintained a price target of $7 for the stock. No additional financial figures or strategic changes were mentioned in the article.